Sign in
CompletedPhase 4

Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
60 people enrolled
Started
13 Aug 2024
Ended
30 Mar 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Ropivacaine
  • Ropivacaine+Dexamethasone
Record updated
23 July 2025

Who can take part

Age
65 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • patients scheduled for total hip arthroplasty
  • patients aged >65 and <100 years
  • patients able to provide informed consent
  • patients able to reliably report symptoms to the research team

Who cannot take part

  • inability to provide first-party consent due to cognitive impairment or a language barrier

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Effect of adding Dexamethasone to Infiltration between the Popliteal Artery and Capsule of the Knee Block with ACB in Patients undergoing Total Knee Arthroplasty

The 2 groups in the trial

  • RopivacaineExisting treatment, for comparison

    iPACK Block + ACB with Ropivacaine

  • Ropivacaine + DexamethasoneExisting treatment, for comparison

    iPACK Block + ACB with Ropivacaine + Dexamethasone

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Infiltration Between the Popliteal Artery and Capsule of the Knee Block With Adductor Canal Block With Ropivacaine vs Ropivacaine and Dexamethasone in Total Knee Arthroplasty: A Randomized Controlled Trial
Record updated
23 July 2025